Clinical trial
Study of Molecular Profile-Related Evidence to Determine Individualized Therapy…
NCT02534675 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT02534675 |
|---|---|
| Title | Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers |
| Official title | An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Malignancies and Poor Prognosis |
| Acronym | I-PREDICT |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | Foundation Medicine Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Cancer |
| Enrollment | 506 |
| Start date | Feb 1, 2015 |
| Primary completion | Dec 17, 2020 |
| Completion | Dec 1, 2022 |
| First posted | Aug 28, 2015 |
| Last update posted | Mar 29, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: